Genius Receives Approval From Health Canada

MONTREAL, QUEBEC--(Marketwired - July 7, 2015) - Genius Properties Ltd. (the "Corporation") (CSE:GNI) is proud to announce that it has received approval from Health Canada for the commercialization of 4 of its Reïva brand products.

According to Dr Guy Chamberland, M.Sc., Ph.D., the person responsible for product development for Reïva, the company has received approval for four of its novel natural health products to be sold under the Reïva brand. Health Canada granted the Natural Product Numbers (NPN) after reviewing the evidence submitted in support of the safety, efficacy and quality of the products. These four products target conditions, such as sexual health, muscle recovery process associated with a resistance training regimen, enhancing physical capacity/performance, and supporting cardiovascular health.

According to Dr Chamberland, these product approvals will allow the corporation to meet its target date for commercialization and product launch. These four products were designed for athletes and health minded consumers seeking natural and healthy products for wellness. Some are innovative products for adults and others can be safely used by both adolescents and adults.

About Reïva

REÏVA has developed six novel consumer products focussed on the principle of health and wellness. Natural and functional beverages and products to meet the needs of athletes and or the health-minded consumers. Developed in collaboration with universities and independent laboratories.

REÏVA has crafted a world class formula manufactured in Quebec, Canada. We believe we have delivered a new way to experience health and wellness products. It is our commitment to create a new platform in the health and wellness production. To deliver products of the highest quality and to be established as the new standard of a health and wellness brand.

YOU JUST CAN'T BEAT BEET

Recent scientific research has proven that drinking nitrate rich beetroot juice before exercising will improve an athlete's endurance, stamina and power.

The "REÏVA" products include the following features:

• They have a first choice antioxidant power;
• They greatly improve sports performances;
• They improve blood circulation;
• They improve control on good and bad cholesterol;
• They have recognized cardiovascular features;
• They are high quality dietary supplements;
• They help the body metabolize carbohydrates, fats and proteins;
• They help maintain good muscular functions;
• They help the regeneration of red blood cells;
• They reinforce the immune system;
• And much more.

About Genius

Genius is an international firm dedicated to building, buying, investing, and representing the next generation of brands. We focus on selecting and marketing brands that are innovative, eco-friendly, and/or are market disruptors. We only work with brands that have scalable revenue potential.

A Proven Team and Formula

• Ensures systems are in place to conduct business
• Provides the execution strategy for launching brands
• Develops powerful presentations for launch of products
• Creates marketing programs that are affordable but look like tier 1 companies
• Build national and international sales teams to successfully launch products with great potential

This news release contains forward-looking information within the meaning of applicable Canadian securities laws. All information other than historical fact is forward-looking information. Forward-looking information relates to future events or future performance and is based on Genius' current internal expectations, estimates, projections, assumptions and beliefs. Forward-looking information is often, but not always, identified by the use of words such as "expect", "project", "proposed", "intend", "seek", "anticipate", "budget", "plan", "continue", "estimate", "forecast", "may", "will", "predict", "potential", "targeting", "could", "might", "should", "believe" and similar expressions. Although management considers the assumptions and estimates, reflected in forward-looking information, to be reasonable, based on information currently available, there can be no assurance that such information will prove to be correct. As a consequence, actual results may differ materially from those anticipated.

Undue reliance should not be placed on forward-looking information which is inherently uncertain, and subject to known and unknown risks and uncertainties (both general and specific) and other factors that contribute to the possibility that the future events or circumstances contemplated by the forward looking information will not occur or that may cause the actual results, level of activity, performance or achievements of the Corporation to be materially different from those expressed or implied by such forward-looking information. These risks include, but are not limited to risks associated with general economic conditions, the actual results of current exploration activities, conclusions of economic evaluations, changes in project parameters as plans continue to be refined, future metal prices, financial risks and substantial capital requirements. Further information regarding certain of these risks (as well as risks relating generally to the Corporation's business) may be found under the headings "Risks and Uncertainties", "Forward-Looking Information" and "Financial risk factors" in the latest Corporation's Management's Discussion & Analysis on www.sedar.com. Readers are cautioned that the foregoing list of factors that may affect future results is not exhaustive. The forward-looking statements contained in this news release are made as of the date hereof and Genius does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.

The CSE has neither approved nor disapproved the contents of this press release. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.